[SLRX] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
27-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 54.77%
YoY- -57.90%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 18 0 -1,840 1,479 1,039 163 283 -36.80%
PBT -882 -6,371 -4,105 -1,768 -1,882 -2,009 -8,029 -30.78%
Tax -0 111 -44 10 1 -51 -74 -
NP -882 -6,482 -4,105 -1,768 -1,883 -2,009 -8,029 -30.78%
Tax Rate - - - - - - - -
Total Cost 900 6,482 2,265 3,246 2,922 2,172 8,312 -30.95%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -4,928.44 0.00 223.06 -119.52 -181.27 -1,232.52 -2,837.10 9.63%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.22 -2.88 -2.27 -2.84 -14.40 -69.50 -284.43 -69.68%
EPS Diluted -0.22 -2.88 -2.27 -2.84 -14.40 -69.50 -284.43 -69.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.